Document is current
Any future updates will be listed below
-
Authors
Mukadi-Kakoni, Patrick
Munyeku-Bazitama, Yannick
Kashitu-Mujinga, Gracia
Manwana-Pemba, Marguerite
Zenga-Bibi, Niclette
Okitale-Talunda, Patient
Mbelu-Kabongo, Christelle
Domai-Mbuyakala, Fleurette
Pukuta-Simbu, Elisabeth
Mutantu-Nsele, Pierre
Kubo, Yoshinao
Makiala-Mandanda, Sheila
Ahuka-Mundeke, Steve
Ariyoshi, Koya
Muyembe-Tamfum, Jean-Jacques
-
Funding
Funding for this research was provided by:
Nagasaki University World-Leading Innovative and Smart Education (WISE) Program
- License Information
-
More Information
Article History
Received: 11 January 2025
Accepted: 16 January 2025
First Online: 5 February 2025
Declarations
:
: This study was approved by the Institutional Review Board of the Institute of Tropical Medicine, Nagasaki University (Approval No. 230615290) and conducted in accordance with the ethical principles outlined in the 1964 Declaration of Helsinki. This study was part of the DRC Ministry of Public Health's Yellow Fever Surveillance Initiative, conducted by the Institut National de Recherche Biomédicale (INRB), with authorization from the DRC Ministry of Health. It aims to enhance the utilization of yellow fever surveillance data in the DRC using anonymized samples and data without personal identifiers, thus negating the need for informed consent. This retrospective study design ensured participant privacy and confidentiality and adhered to the ethical guidelines for medical research.
: Not applicable.
: The authors declare no competing interests.
